Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2008
12/04/2008WO2008099144A3 Tgf-beta stimulant and further agent to reduce side effects
12/04/2008WO2008094992A3 2-aminopyridine derivatives useful as kinase inhibitors
12/04/2008WO2008079933A3 Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections
12/04/2008WO2008076257A3 Treating cancer with anti-igflr antibody 19d12 = sch 717454
12/04/2008WO2008070350A3 Methods and compositions related to wrapping of dehydrons
12/04/2008WO2008063229A3 Enzymatic debridement therapy for abnormal cell proliferation
12/04/2008WO2008060645A3 Combinatorial therapy involving alpha5beta1 antagonists
12/04/2008WO2008055703A3 Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates
12/04/2008WO2008033749A3 Quinazoline based egfr inhibitors containing a zinc binding moiety
12/04/2008WO2008033747A3 Multi-functional small molecules as anti-proliferative agents
12/04/2008WO2007134533A8 20(R)-GINSENOSIDE Rg3 MEDICINAL SOLUBLE INTERMEDIATE AND PROCESS THEREOF
12/04/2008WO2007110623A3 Screening method
12/04/2008WO2007092496A3 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors
12/04/2008US20080300398 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents; HIV
12/04/2008US20080300384 T-bet compositions and methods of use thereof
12/04/2008US20080300312 Treatment of cancer with specific RXR agonists
12/04/2008US20080300299 Application of Eriocalyxin B in the Manufacture of Medicaments For Treating Leukemia
12/04/2008US20080300298 Honokiol Derivates For the Treatment of Proliferative Disorders
12/04/2008US20080300297 Taxane derivative containing pharmaceutical composition with improved therapeutic efficacy
12/04/2008US20080300291 Potent indole-3-carbinol-derived antitumor agents
12/04/2008US20080300278 central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; gastrointestinal disorders; eating disorders; antidiabetic agents; anticancer agents; cardiovascular disorders
12/04/2008US20080300274 Novel Pyrrolidino-1,4-Naphthoquinone Deriviatives and their Use for Treating Malignancies and Cardiovascular Diseases
12/04/2008US20080300273 Method of Treating Abnormal Cell Growth
12/04/2008US20080300271 Novel compounds and a novel process for their preparation
12/04/2008US20080300268 Heterocyclic compounds and uses thereof
12/04/2008US20080300267 (3-Chloro-phenyl)-[4-(1H-pyrrolo[2,3-b]pyridin-4-yl)-pyrimidin-2-yl]-amine; (4-Fluoro-phenyl)-[4-(1H-pyrrolo[2,3-b]pyridin-4-yl)-pyrimidin-2-yl]-amine; [4-(1H-Pyrrolo[2,3-b]pyridin-4-yl)-pyrimidin-2-yl]-(4-trifluoromethoxy-phenyl)-amine;
12/04/2008US20080300263 Pyrazolo [1,5-a] pyrimidine compounds and pharmaceutical compositions containing them
12/04/2008US20080300251 Derivatives of 3-Azabicyclo[3.1.0] Hexane as Dipeptidyl Peptidase-IV Inhibitors
12/04/2008US20080300249 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents
12/04/2008US20080300248 Quinazoline Derivatives, Preparation Methods and Uses Thereof
12/04/2008US20080300247 Benzimidazole Thiophene Compounds
12/04/2008US20080300246 Compounds and Compositions as Protein Kinase Inhibitors
12/04/2008US20080300245 such as pyrazolo[1,5-a]pyridine-3-carboxylic acid [2-methyl-5-(3-trifluoromethyl-benzoylamino)-phenyl]-amide, used for treating cancer, nervous sytem disorders, restenosis, crohn's disease, vision defects, liver disorders, glomerulonephritis, inflammatory bowel disease and skin disorders
12/04/2008US20080300244 Novel compounds
12/04/2008US20080300242 Imidazopyridine Kinase Inhibitors
12/04/2008US20080300241 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
12/04/2008US20080300239 Quinoline derivatives as pi3 kinase inhibitors
12/04/2008US20080300238 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
12/04/2008US20080300234 N-(1-Methyl-1-phenyl-ethyl)-3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-benzenesulfonamide, useful in the treatment of breast cancer
12/04/2008US20080300230 Use of extracts of the genus cimicifuga as organoselective medicines for treating diseases of the genitourinary tract caused by sex hormones
12/04/2008US20080300223 (20R)-2a-Methyl-19,26,27-Trinor-Vitamin D Analogs
12/04/2008US20080300220 Linkable Lewis X Analogs
12/04/2008US20080300196 Monosaccharide derivatives
12/04/2008US20080300192 Auristatins Having an Aminobenzoic Acid Unit at the N Terminus
12/04/2008US20080300177 Provided are lactam-cyclized peptide CXCR4 antagonists (g-coupled protein receptor inhibitors) and a ligand SDF-1 (stromal cell-derived factor-1) useful in the in the treatment of cancers, rheumatoid arthritis, pulmonary fibrosis, and HIV infection
12/04/2008US20080300166 Treatment of Melanoma with Alpha Thymosin Peptides
12/04/2008US20080299642 Vectors with modified protease-dependent tropism
12/04/2008US20080299547 Novel stra6 polypeptides
12/04/2008US20080299182 Methods and formulations for topical gene therapy
12/04/2008US20080299180 Peptides based on the sequence of human lactoferrin and their use
12/04/2008US20080299138 Toll-Like Receptor 3 Modulators and Uses Thereof
12/04/2008US20080299137 Fusion Proteins That Bind Effector Lymphocytes And Target Cells
12/04/2008US20080299136 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders
12/04/2008US20080299134 Recombinant Anti-Interleukin-9 Antibodies
12/04/2008US20080299124 Novel method for the stabilization of chimeric immunoglobulin or immunoglobulin fragments and, and stabilized anti-egp-2 scfv fragment
12/04/2008US20080299120 Multivalent antibodies and uses therefor
12/04/2008US20080299118 FXR Agonists for the Treatment of Malignancies
12/04/2008US20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof
12/04/2008US20080299113 Combined treatment with and composition of 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents
12/04/2008US20080299112 Human Polyclonal Antibodies from Genetically Engineered Animals
12/04/2008US20080299100 Topical Co-Enzyme Q10 Formulations and Methods of Use
12/04/2008US20080299083 Adenoviral vectors having a protein IX deletion
12/04/2008US20080299081 Polynucleotides and Polypeptides of the IFNalpha-21 Gene
12/04/2008US20080299076 Compunds and compositions that cause non-apoptotic cell death and uses thereof
12/04/2008US20080299071 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
12/04/2008US20080299046 Methods for controlling surface functionality of metal oxide nanoparticles, metal oxide nanoparticles having controlled functionality, and uses thereof
12/04/2008US20080299040 Diagnosis and therapy of cancer and noncancerous diseases; complexes with radioactive material
12/04/2008US20080299039 Aprotinin Polypeptides for Transporting a Compound Across the Blood-Brain Barrier
12/04/2008DE102007025718A1 Pyridazinonderivate Pyridazinone derivatives
12/04/2008CA2689664A1 Cancer treatment combination therapy comprising vinflunine and trastuzumab
12/04/2008CA2689090A1 Kinase inhibitor
12/04/2008CA2688518A1 Pyridazinone derivatives for use in the treatment of a disease which is influenced by inhibiton of met kinase
12/04/2008CA2688517A1 Aryl ether pyridazinone derivatives for use in the treatment of tumours
12/04/2008CA2688486A1 Sesquiterpene formulations, kits and methods of use thereof
12/04/2008CA2688410A1 A composition comprising camomile and black cumin oil and therapeutic uses thereof
12/04/2008CA2688346A1 Compositions and methods for enhancing immune responses to vaccines
12/04/2008CA2688344A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
12/04/2008CA2688336A1 Compositions comprising an extract of tiarella polyphylla or compounds isolated therefrom for preventing and treating cancer diseases
12/04/2008CA2688326A1 Tetrahydroisoquinolin-1-one derivative or salt thereof
12/04/2008CA2688293A1 Dietary formulations and methods for treatment of inflammation and other disorders
12/04/2008CA2687786A1 Combination of chk and parp inhibitors for the treatment of cancers
12/04/2008CA2687586A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity
12/04/2008CA2687583A1 Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity
12/04/2008CA2687575A1 Humanized and chimeric anti-cd59 antibodies that mediate cancer cell cytotoxicity
12/04/2008CA2687574A1 Compositions useful for reducing nephrotoxicity and methods of use thereof
12/04/2008CA2687206A1 Monoclonal antibodies against claudin-18 for treatment of cancer
12/04/2008CA2686787A1 Raf inhibitors for the treatment of thyroid cancer
12/03/2008EP1997894A2 Biosynthetic binding protein for cancer marker
12/03/2008EP1997893A1 Compositions containing an OX-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/03/2008EP1997884A1 Novel human t cell population
12/03/2008EP1997832A1 Monoclonal antibodies against Claudin-18 for treatment of cancer
12/03/2008EP1997829A1 Albumin fusion proteins
12/03/2008EP1997823A1 Boronic ester and acid compounds, synthesis and uses
12/03/2008EP1997811A2 Indazole, benzoxazole and pyrazolopyridine derivatives as P38 kinase inhibitors
12/03/2008EP1997804A1 Mmp-13-selective inhibitor
12/03/2008EP1997506A1 Use of ck2 inhibitor for the treatment and chemosensibilization of refractory tumors to anticancer drugs
12/03/2008EP1997503A2 Treatment of melanoma with alpha thymosin peptides
12/03/2008EP1997498A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
12/03/2008EP1997494A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto
12/03/2008EP1997492A1 Method of treatment
1 ... 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 ... 2211